List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 22 studies with search of: mozobil
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant
Conditions: Multiple Myeloma;   Non-Hodgkins Lymphoma;   Hodgkins Disease
Intervention: Drug: Plerixafor
2 Recruiting Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With De Novo Acute Myeloid Leukemia
Condition: De Novo Acute Myeloid Leukemia
Intervention: Drug: Plerixafor
3 Recruiting A Phase I Study of Mozobil(Trademark) in the Treatment of Patients With WHIMS
Conditions: WHIMS;   Neutrophil Disorder;   Myelokathexis;   Hypogammaglobulinemia
Intervention: Drug: Mozobil (TM)
4 Recruiting Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Plerixafor (AMD3100);   Drug: bortezomib
5 Not yet recruiting Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia
Condition: Leukemia, Myeloid, Acute
Interventions: Drug: G-CSF;   Drug: Plerixafor;   Drug: Mitoxantrone;   Drug: Etoposide;   Drug: Cytarabine
6 Recruiting Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin
Conditions: Stem Cell Transplantation;   Leukemia
Interventions: Drug: Plerixafor;   Drug: Filgrastim;   Drug: Fludarabine;   Drug: Busulfan;   Procedure: Allogeneic blood stem cell transplant;   Drug: ATG (Thymoglobulin)
7 Not yet recruiting Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations
Conditions: Acute Myelogenous Leukemia;   Leukemia
Interventions: Drug: G-CSF;   Drug: Plerixafor;   Drug: Sorafenib
8 Not yet recruiting Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide and Planning to Undergo Autologous Stem Cell Transplant
Conditions: Multiple Myeloma;   Refractory Multiple Myeloma;   Stage I Multiple Myeloma;   Stage II Multiple Myeloma;   Stage III Multiple Myeloma
Interventions: Drug: plerixafor;   Drug: filgrastim
9 Recruiting This is a Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM.
Conditions: Lymphoma (Non-Hodgkin's Lymphoma);   Hodgkin's Disease or Multiple Myeloma;   Front Line Mobilization, Transplantation
Intervention: Drug: Generic = Plerixafor
10 No longer available This is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor for Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) Who Are to Receive Treatment With an Autologous Peripheral Stem Cell Transplant.
Conditions: Non-Hodgkin's Lymphoma;   Hodgkin's Disease;   Multiple Myeloma
Intervention: Drug: Plerixafor
11 Recruiting Study of AMD3100 and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Chronic Lymphocytic Leukemia (CLL);   Small Lymphocytic Lymphoma (SLL)
Intervention: Drug: Plerixafor
12 Enrolling by invitation Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study.
Conditions: Non-Hodgkin's Lymphoma;   Autologous Transplantation
Intervention:
13 Enrolling by invitation Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3102 Study.
Conditions: Multiple Myeloma;   Autologous Transplantation
Intervention:
14 Recruiting Intravenous (IV) AMD3100 for Mobilization and Matched Related Transplant for Advanced Hematological Malignancies
Condition: Hematologic Neoplasms
Intervention: Drug: AMD3100
15 Recruiting Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With Lymphoma
Conditions: Lymphoma, Non-Hodgkin;   Hodgkin Disease
Interventions: Drug: AMD3100;   Drug: G-CSF;   Procedure: Apheresis
16 Recruiting AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia
Condition: Leukemia, Myeloid, Acute
Interventions: Drug: AMD3100;   Drug: Mitoxantrone;   Drug: Etoposide;   Drug: Cytarabine
17 Active, not recruiting Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies
Conditions: Leukemia, Myeloid, Acute;   Leukemia, Myelogenous, Chronic;   Leukemia, Lymphoblastic, Acute;   Lymphocytic Leukemia, Chronic;   Myelodysplastic Syndromes;   Multiple Myeloma;   Lymphoma, Non-Hodgkin;   Hodgkin Disease
Intervention: Drug: AMD3100
18 Completed Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM).
Conditions: Lymphoma;   Non Hodgkin's Lymphoma;   Hodgkin's Disease;   Multiple Myeloma
Interventions: Drug: Plerixafor (AMD3100);   Drug: Can be any registered nonpegylated form of G-CSF
19 Completed Mobilization of Stem Cells With AMD3100 in Multiple Myeloma Patients
Condition: Multiple Myeloma
Interventions: Drug: AMD3100;   Drug: Placebo + G-CSF
20 Completed AMD3100 Added to a Mobilizing Regimen of G-CSF to Increase the Number of PBSCs in Patients With Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Drug: AMD3100

Previous Page Studies Shown (1-20) Next Page (21-22)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services